Filed: 2/14/2025ACC: 0001636587-25-000009
📋 What this filing means
ACORN CAPITAL ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 20 equity positions with a total reported market value of $185.04M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
20
Positions
$185.04M
Total AUM (reported)
35.28M
Total Shares
Allocation by class
COM$156.30M84.5%
CLASS A COM$10.25M5.5%
COM NEW$9.30M5.0%
COM STK$6.76M3.7%
COMMON STOCK$2.44M1.3%
Portfolio Concentration
Top 3$71.70M38.7%
4–10$75.54M40.8%
11–25$37.80M20.4%
Top 3 weight
38.7%
Top 10 weight
79.6%
Voting Authority Distribution
Total shares with voting rights: 35.28M
Sole
Full voting authority
35.28M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole20
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings20
Rows:
CG ONCOLOGY INC
SOLEShares1.13M
TypeSH
Market value$32.45M
17.54%
Sole
1.13M
Shared
0.00
None
0.00
Y-MABS THERAPEUTICS INC
SOLEShares2.86M
TypeSH
Market value$22.41M
12.11%
Sole
2.86M
Shared
0.00
None
0.00
CANDEL THERAPEUTICS INC
SOLEShares1.94M
TypeSH
Market value$16.84M
9.10%
Sole
1.94M
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares1.52M
TypeSH
Market value$16.15M
8.73%
Sole
1.52M
Shared
0.00
None
0.00
PUMA BIOTECHNOLOGY INC
SOLEShares2.45M
TypeSH
Market value$12.02M
6.49%
Sole
2.45M
Shared
0.00
None
0.00
BICARA THERAPEUTICS
SOLEShares643.38K
TypeSH
Market value$11.21M
6.06%
Sole
643.38K
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares1.97M
TypeSH
Market value$10.92M
5.90%
Sole
1.97M
Shared
0.00
None
0.00
ONKURE THERAPEUTICS INC
SOLEShares1.44M
TypeSH
Market value$10.25M
5.54%
Sole
1.44M
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares2M
TypeSH
Market value$8.24M
4.46%
Sole
2M
Shared
0.00
None
0.00
PROTARA THERAPEUTICS INC
SOLEShares1.28M
TypeSH
Market value$6.76M
3.65%
Sole
1.28M
Shared
0.00
None
0.00
CYBIN INC
SOLEShares734.39K
TypeSH
Market value$6.48M
3.50%
Sole
734.39K
Shared
0.00
None
0.00
CARDIF ONCOLOGY INC
SOLEShares1.44M
TypeSH
Market value$6.26M
3.38%
Sole
1.44M
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares7.31M
TypeSH
Market value$5.36M
2.90%
Sole
7.31M
Shared
0.00
None
0.00
MURAL ONCOLOGY PLC
SOLEShares1.29M
TypeSH
Market value$4.14M
2.24%
Sole
1.29M
Shared
0.00
None
0.00
AADI BIOSCIENCE INC
SOLEShares1.15M
TypeSH
Market value$3.62M
1.96%
Sole
1.15M
Shared
0.00
None
0.00
OPTINOSE INC
SOLEShares422.81K
TypeSH
Market value$2.82M
1.53%
Sole
422.81K
Shared
0.00
None
0.00
Q32 BIO INC.
SOLEShares803.42K
TypeSH
Market value$2.76M
1.49%
Sole
803.42K
Shared
0.00
None
0.00
ACRIVON THERAPEUTICS INC
SOLEShares405.24K
TypeSH
Market value$2.44M
1.32%
Sole
405.24K
Shared
0.00
None
0.00
BIOATLA INC
SOLEShares4.03M
TypeSH
Market value$2.38M
1.29%
Sole
4.03M
Shared
0.00
None
0.00
VYNE THERAPEUTICS INC
SOLEShares456.97K
TypeSH
Market value$1.53M
0.83%
Sole
456.97K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY INCSOLE | COM | 1.13M | SH | $32.45M 17.54% | 1.13M | 0.00 | 0.00 |
Y-MABS THERAPEUTICS INCSOLE | COM | 2.86M | SH | $22.41M 12.11% | 2.86M | 0.00 | 0.00 |
CANDEL THERAPEUTICS INCSOLE | COM | 1.94M | SH | $16.84M 9.10% | 1.94M | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 1.52M | SH | $16.15M 8.73% | 1.52M | 0.00 | 0.00 |
PUMA BIOTECHNOLOGY INCSOLE | COM | 2.45M | SH | $12.02M 6.49% | 2.45M | 0.00 | 0.00 |
BICARA THERAPEUTICSSOLE | COM | 643.38K | SH | $11.21M 6.06% | 643.38K | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 1.97M | SH | $10.92M 5.90% | 1.97M | 0.00 | 0.00 |
ONKURE THERAPEUTICS INCSOLE | CLASS A COM | 1.44M | SH | $10.25M 5.54% | 1.44M | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 2M | SH | $8.24M 4.46% | 2M | 0.00 | 0.00 |
PROTARA THERAPEUTICS INCSOLE | COM STK | 1.28M | SH | $6.76M 3.65% | 1.28M | 0.00 | 0.00 |
CYBIN INCSOLE | COM NEW | 734.39K | SH | $6.48M 3.50% | 734.39K | 0.00 | 0.00 |
CARDIF ONCOLOGY INCSOLE | COM | 1.44M | SH | $6.26M 3.38% | 1.44M | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM | 7.31M | SH | $5.36M 2.90% | 7.31M | 0.00 | 0.00 |
MURAL ONCOLOGY PLCSOLE | COM | 1.29M | SH | $4.14M 2.24% | 1.29M | 0.00 | 0.00 |
AADI BIOSCIENCE INCSOLE | COM | 1.15M | SH | $3.62M 1.96% | 1.15M | 0.00 | 0.00 |
OPTINOSE INCSOLE | COM NEW | 422.81K | SH | $2.82M 1.53% | 422.81K | 0.00 | 0.00 |
Q32 BIO INC.SOLE | COM | 803.42K | SH | $2.76M 1.49% | 803.42K | 0.00 | 0.00 |
ACRIVON THERAPEUTICS INCSOLE | COMMON STOCK | 405.24K | SH | $2.44M 1.32% | 405.24K | 0.00 | 0.00 |
BIOATLA INCSOLE | COM | 4.03M | SH | $2.38M 1.29% | 4.03M | 0.00 | 0.00 |
VYNE THERAPEUTICS INCSOLE | COM | 456.97K | SH | $1.53M 0.83% | 456.97K | 0.00 | 0.00 |